News
Will the Indian Pharma remain muted or grow FY 17 ?
Register muted export revenue and stable domestic revenue in India to be expected to increase in the next budgetary year. 5 per cent of overall pharmaceutical exports and 8-10 per cent on domestic pharma is expected. Speaking about the exports, current PM Narendra Modi has brought up “come make in India” in which
India’s Biotech Moment in February
The fear of Zika virus infection, has not been reported in India, but the America is the first country in the world to test not just one but two vaccines against the virus that is causing nightmares. India might have not proven to be a full fledged vaccine manufacturer but
CDSCO planning to bring down the price of Hepatitis Treatment in India
12 million people are affected by Hepatitis C in India. India is one of the few countries in the world which have generics for interferon – free treatment, to help combat the disease. Also, fresh hope to patients as the Apex Committee of the Central Drugs Standard Control Organisation (CDSCO),
Medical Devices to Be Regulated Independently in this Country?
In most Asian countries including South Korea, Indonesia, Thailand, Malaysia, Philippines, Singapore and Vietnam medical devices are regulated separately from drugs. However, in India currently medical devices, drugs, IVD’s and cosmetics are all regulated under the same Drugs and Cosmetics Act. The new government under Modi is keen on delinking the medical device
India to Make these Changes to Encourage Export of Medical Devices
The South East Asia Medical Device markets including Korea, Indonesia, Thailand, Malaysia, India, Philippines, Singapore, Malaysia and Vietnam have been growing at a higher rate than the developed medical device markets of the Western world. These countries have shown high rate of imports in medical devices, larger expenditure by the private and
Register with Pharma Data Bank or Face Penal Action
Drugs in India are regulated by the CDSCO and the NPPA. The CDSCO monitors clinical trials, regulatory approvals, import / export and quality control for pharmaceutical products, whilst the NPAA is involved in the price regulation for pharmaceuticals in the Indian market. The National Pharmaceutical Pricing Authority (NPPA) has set
Ethics Committee Accreditation is Essential Now in this Country
The Central Drug Standards Control Organisation regulates the clinical trials for drugs and medical devices in India. Demonstration of safety and efficacy of the drug product for use in humans is essential before the drug product can be approved for import or manufacturing and marketing in the country (Read About
India’s first dedicated Medical Device Park to come up in Andhra Pradesh
The 200 acre exclusive park will spur domestic production of medical devices, help reduce import dependency in this sector while creating employment and growth in the state. India primarily depends on imports for the medical device sector. Over 85% of medical devices are imported into the country causing a high
India’s CDSCO Offers Four New Updates to Promote Clinical Research
The Central Drugs Standard Control Organization (CDSCO) is the primary body which regulates medical devices, drugs, cosmetics, in vitro diagnostics in the Indian subcontinent. This body is also responsible for the monitoring and approval of clinical trials and research in the country. Early this year, several amendments were made the
Centre sanctions US$ 150 bn to CDSCO for integrating e-governance across states with national portal
The Central Drugs Standard Control Organization (CDSCO) is currently undergoing several transformations to upgrade the regulatory systems for medical devices, drugs, in vitro diagnostics and cosmetic approval processes. The registration process is done with New Delhi as the Head Quarters. By linking the different offices with e-governance the CDSCO would improve